Boothbay Fund Management’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $864K | Buy |
132,891
+86,145
| +184% | +$560K | 0.02% | 573 |
|
|
2025
Q1 | $378K | Sell |
46,746
-14,719
| -24% | -$119K | 0.01% | 813 |
|
|
2024
Q4 | $760K | Sell |
61,465
-112,647
| -65% | -$1.39M | 0.02% | 603 |
|
|
2024
Q3 | $1.43M | Buy |
174,112
+6,556
| +4% | +$53.8K | 0.03% | 528 |
|
|
2024
Q2 | $836K | Sell |
167,556
-4,370
| -3% | -$21.8K | 0.02% | 666 |
|
|
2024
Q1 | $1.06M | Buy |
+171,926
| New | +$1.06M | 0.02% | 627 |
|
|
2023
Q2 | – | Sell |
-23,166
| Closed | -$100K | – | 2084 |
|
|
2023
Q1 | $100K | Buy |
23,166
+7,066
| +44% | +$30.6K | ﹤0.01% | 1687 |
|
|
2022
Q4 | $113K | Buy |
+16,100
| New | +$113K | ﹤0.01% | 1514 |
|
|
2022
Q3 | – | Sell |
-27,932
| Closed | -$91K | – | 2333 |
|
|
2022
Q2 | $91K | Sell |
27,932
-86,347
| -76% | -$281K | ﹤0.01% | 1734 |
|
|
2022
Q1 | $229K | Hold |
114,279
| – | – | 0.01% | 1425 |
|
|
2021
Q4 | $359K | Hold |
114,279
| – | – | 0.01% | 1027 |
|
|
2021
Q3 | $560K | Buy |
+114,279
| New | +$560K | 0.02% | 847 |
|
|
2020
Q3 | – | Sell |
-16,000
| Closed | -$167K | – | 1132 |
|
|
2020
Q2 | $167K | Buy |
+16,000
| New | +$167K | 0.01% | 697 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 992 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 927 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 835 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 821 |
|